Aurobindo Pharma Gets USFDA Approval for Icatibant Injection

 A significant achievement for Aurobindo Pharma emerges as its wholly-owned subsidiary, Eugia Pharma Specialities, gains the final green light from the US health authority for the production and distribution of a generic Icatibant injection. This injection is integral in addressing hereditary angioedema. The endorsement, bestowed by the US Food & Drug Administration (USFDA), pertains to …

Aurobindo Pharma Gets USFDA Approval for Icatibant Injection Read More »